Ubs Asset Management Americas Inc Biotechnology

Ubs Asset Management Americas Inc

$379 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
PHVS Pharvaris N.V.	$677M	$1.07 Million 0.0% of portfolio	68,331	Q1 2025 Added 7.21%
KURA Kura Oncology, Inc.	$433M	$1 Million 0.0% of portfolio	152,132	Q1 2025 Added 15.5%
BGNE Bei Gene, Ltd.	$23.5B	$903,000 0.0% of portfolio	3,986	Q1 2025 Added 19.48%
DAWN Day One Biopharmaceuticals, Inc.	$530M	$890,000 0.0% of portfolio	112,279	Q1 2025 Added 48.56%
COGT Cogent Biosciences, Inc.	$802M	$888,000 0.0% of portfolio	148,280	Q1 2025 Added 9.35%
ENTA Enanta Pharmaceuticals Inc	$152M	$880,000 0.0% of portfolio	159,497	Q1 2025 Reduced 0.15%
AVXL Anavex Life Sciences Corp.	$993M	$846,000 0.0% of portfolio	98,634	Q1 2025 New
REPL Replimune Group, Inc.	$153M	$845,000 0.0% of portfolio	86,758	Q1 2025 Added 31.93%
RLAY Relay Therapeutics, Inc.	$442M	$790,000 0.0% of portfolio	301,550	Q1 2025 Added 29.65%
CVAC Cure Vac N.V.	$1.02B	$774,000 0.0% of portfolio	279,656	Q1 2025 Added 1.14%
NUVB Nuvation Bio Inc.	$545M	$767,000 0.0% of portfolio	435,917	Q1 2025 Added 25.33%
RCUS Arcus Biosciences, Inc.	$712M	$764,000 0.0% of portfolio	97,423	Q1 2025 Added 57.1%
CRMD Cor Medix Inc.	$480M	$650,000 0.0% of portfolio	105,676	Q1 2025 New
PHAT Phathom Pharmaceuticals, Inc.	$355M	$625,000 0.0% of portfolio	99,744	Q1 2025 Reduced 15.33%
ERAS Erasca, Inc.	$209M	$610,000 0.0% of portfolio	445,580	Q1 2025 Added 0.18%
VERV Verve Therapeutics, Inc.	$667M	$610,000 0.0% of portfolio	133,566	Q1 2025 Added 11.47%
CGEM Cullinan Oncology, Inc.	$380M	$608,000 0.0% of portfolio	80,353	Q1 2025 Reduced 12.46%
CAPR Capricor Therapeutics, Inc.	$163M	$561,000 0.0% of portfolio	59,166	Q1 2025 Added 76.63%
MRVI Maravai Lifesciences Holdings, Inc.	$356M	$554,000 0.0% of portfolio	250,855	Q1 2025 Reduced 0.14%
STOK Stoke Therapeutics, Inc.	$533M	$550,000 0.0% of portfolio	82,802	Q1 2025 Reduced 13.3%
ALT Altimmune, Inc.	$201M	$534,000 0.0% of portfolio	106,872	Q1 2025 Added 15.67%
IMNM Immunome Inc.	$132M	$527,000 0.0% of portfolio	78,344	Q1 2025 Added 34.63%
EYPT Eye Point Pharmaceuticals, Inc.	$357M	$524,000 0.0% of portfolio	96,811	Q1 2025 Added 7.15%
ARCT Arcturus Therapeutics Holdings Inc.	$397M	$502,000 0.0% of portfolio	47,452	Q1 2025 Reduced 9.08%
SANA Sana Biotechnology, Inc.	$976M	$478,000 0.0% of portfolio	284,924	Q1 2025 Added 2.02%
SVRA Savara Inc	$291M	$440,000 0.0% of portfolio	159,052	Q1 2025 Added 1.32%
HUMA Humacyte, Inc.	$275M	$414,000 0.0% of portfolio	242,616	Q1 2025 Added 19.62%
ABUS Arbutus Biopharma Corp	$486M	$401,000 0.0% of portfolio	114,950	Q1 2025 Added 10.59%
ATXS Astria Therapeutics, Inc.	$99.9M	$338,000 0.0% of portfolio	63,452	Q4 2024 Added 13.93%
ARGX Argenx Se	$32.7B	$337,000 0.0% of portfolio	570	Q1 2025 Reduced 97.21%
TYRA Tyra Biosciences, Inc.	$452M	$331,000 0.0% of portfolio	35,635	Q4 2024 Added 41.36%
TRDA Entrada Therapeutics, Inc.	$200M	$303,000 0.0% of portfolio	33,593	Q1 2025 Reduced 6.03%
PLRX Pliant Therapeutics, Inc.	$77.4M	$209,000 0.0% of portfolio	154,906	Q1 2025 Added 10.98%
ANNX Annexon, Inc.	$121M	$152,000 0.0% of portfolio	78,857	Q1 2025 Added 60.73%
GLUE Monte Rosa Therapeutics, Inc.	$267M	$111,000 0.0% of portfolio	24,100	Q1 2025 New
IMCR Immunocore Holdings PLC	$1.55B	$86,000 0.0% of portfolio	2,900	Q1 2025 New
ABSI Absci Corp	$326M	$78,000 0.0% of portfolio	31,175	Q1 2025 New
BCYC Bicycle Therapeutics PLC	$255M	$43,000 0.0% of portfolio	5,100	Q1 2025 New
XBIT X Biotech Inc.	$88.6M	$43,000 0.0% of portfolio	13,500	Q1 2025 New
ZLAB Zai Lab LTD	$3.7B	$43,000 0.0% of portfolio	1,200	Q1 2025 Reduced 97.9%
SAVA Cassava Sciences Inc	$101M	$26,000 0.0% of portfolio	17,424	Q1 2025 Reduced 76.79%
ITOS I Teos Therapeutics, Inc.	$361M	$12,000 0.0% of portfolio	2,154	Q1 2025 New
FULC Fulcrum Therapeutics, Inc.	$407M	$2,000 0.0% of portfolio	703	Q1 2025 New
IGMS Igm Biosciences, Inc.	$37.1M	$1,000 0.0% of portfolio	1,164	Q1 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	279,840	Q1 2025 Added 13.15%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.